All News

Circulating tumor DNA-based minimal residual disease lent insight into which patients with stage 2/3 colorectal cancer may be at higher risk for recurrence and which could benefit from postsurgical chemotherapy.

Patients with unresectable hepatocellular carcinoma and poor liver function were more likely to experience serious side effects leading to regorafenib treatment discontinuation, researchers have found.

Dexter Scott King, son of Martin Luther King, Jr., died of prostate cancer the same day MLB Hall-of-Famer Ryan Sandberg announced he’s been diagnosed with metastatic disease.

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.

A cancer-related side effect I faced was constipation caused by pain medication.

In patients with esophageal squamous cell carcinoma, the combination of Tecentriq, tiragolumab and chemotherapy improved survival outcomes, research found.

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

In patients with TRK fusion GI cancers, Vitrakvi continued to show improvements regarding responses to treatment, survival and safety, research found.

Months after I was told I was in remission for stage 3B lung cancer, my "normal" shifted as the COVID-19 pandemic arrived.

Keytrida plus Lenvima improved survival and duration of response in patients with advanced hepatocellular carcinoma.

The use of FOLFOXIRI for metastatic colorectal cancer was lower than one what expert was expecting.

The use of the chemotherapy regimen FOLFOXIRI plus Avastin has increased from 2013 to 2022 in patients with metastatic colorectal cancer, particularly in patients aged 50 years and younger.

Certain patients with metastatic colorectal cancer were more likely to have long-term remission to Stivarga treatment, recent research showed.

After being diagnosed with Lynch syndrome, uncertainty has become a constant companion of mine.

Imfinzi plus chemotherapy, when given before surgery, improved pathologic complete response rates, regardless of region, in certain patients with gastric or gastroesophageal junction cancers.

Antiviral treatments play a crucial role in the survival of patients with either hepatitis B or C and liver cancer, but researchers have found that antiviral therapy is “severely underutilized” even among patients who undergo curative surgery.

Treatment with Opdivo and chemotherapy improved survival in patients with gastrointestinal cancers, compared with chemotherapy alone, according to a phase 3 trial.

The FDA amended its approval for Balversa for the treatment of patients with locally advanced or metastatic bladder cancer.

As I reflect upon the past, I wonder: Was I just lucky to have turned my health around after fighting and healing from stage 4 bone cancer?

From Broadway actor Jeff Gorti opening up about his childhood cancer experience to Brian Barczyk of The Reptarium dying, here’s what’s happening in the oncology space this week.

A 45-minute cancer procedure deemed me to be "cancer free," but it did not assuage all my anxieties.

Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients who experience a thromboembolic event (TEE) are at a 20% to 25% risk of death.

Patients with advanced gastric cancers tended to have better survival outcomes when given Opdivo plus chemotherapy, compared to those who were given chemotherapy alone.

When a friend recently asked if I’d ever thought cancer might kill me, I had to think back and examine myself.

Certain tumor characteristics were predictive of which patients with lymphoma may have better outcomes with the CAR-T cell therapy, Yescarta.

BTK degrader NX-5948 has been granted Fast Track designation by the FDA to treat some adults with relapsed or refractory chronic lymphocytic leukemia or relapsed or refractory small lymphocytic lymphoma.

Some with metastatic cancers receiving end-of-life-initiated immunotherapy may have a decreased risk of mortality when treated at a high-volume facility, research found.

The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer.

Whenever I experience a new ache or patch of itchy skin, I immediately think it's a health issue — or a recurrence.

Cancer survivors may face different mental and physical quality of life depending on their socioeconomic factors and age, according to a recent study.